Qiagen targets about 7% constant-currency sales CAGR through 2028 - QGEN News | RalliesQiagen targets about 7% constant-currency sales CAGR through 2028
Q
QGEN• 2028 targets and growth plan
- Qiagen set 2028 targets of about 7% constant-exchange-rate net sales CAGR from 2024-28, with adjusted operating income margin at least 31%.
- Strategy calls for at least $2 billion of 2028 net sales at constant exchange rates from growth pillars, supported by efficiency and digitization.
- Plan targets at least 250 basis points of adjusted operating margin expansion from 2024-28.
- Capital allocation framework includes at least $1 billion of shareholder returns from 2024-28, excluding M&A.
- Product targets include at least $250 million 2028 net sales for QIAcuity dPCR, at least $200 million for QIAstat-Dx.
NOC
•
